AdaptHealth Corp
AdaptHealth Corp (AHCO) is a US-based provider of home medical equipment and related services, specialising in respiratory and chronic-care therapies delivered in patients’ homes. With a market capitalisation of about $1.3 billion, the business benefits from structural trends such as an ageing population and a healthcare shift towards lower-cost, home-based care. Key considerations for investors include exposure to reimbursement and regulatory changes, integration of acquisitions, operational complexity and margin sensitivity to supply and labour costs. Performance can be cyclical and values can rise or fall; past results do not guarantee future returns. This summary is for general educational purposes only and is not personal financial advice — suitability depends on your objectives, risk tolerance and time horizon. Investors should read company filings and consider speaking to a qualified adviser before making decisions.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying AdaptHealth's stock, projecting it could rise to $12.56.
Financial Health
AdaptHealth is generating solid revenue and cash flow, with strong profit margins supporting its growth.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring AHCO
At-Home Healthcare Stocks Explained | FDA Approval
The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug simplifies treatment and reduces the need for hospital visits. This development highlights a broader trend toward at-home care, creating potential investment opportunities in companies that provide related medical devices and healthcare services.
Published: August 30, 2025
Explore BasketRiding The Regulatory Wave In Healthcare
The Department of Justice's investigation into UnitedHealth's Medicare billing practices has cast a shadow over the health insurance industry, potentially leading to stricter oversight. This creates an investment opportunity in companies that provide compliance and auditing services, which are essential for navigating a more complex regulatory environment.
Published: July 25, 2025
Explore BasketSilver Tsunami Solvers
Tap into companies serving the growing senior population's health, housing, and lifestyle needs. These carefully selected stocks represent businesses positioned to benefit from the substantial and increasing purchasing power of older demographics.
Published: June 18, 2025
Explore BasketRest & Recharge
Tap into the booming wellness economy with companies revolutionizing how we sleep and relax. These carefully selected stocks represent innovative leaders in sleep technology, relaxation services, and wellness solutions that are responding to our growing desire for better rest and recovery.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Homecare market tailwinds
Ageing populations and a move towards care at home can support demand, though revenue growth is subject to reimbursement and operational execution.
Services and scale
A mix of equipment sales and recurring services can provide stable cash flows if operations scale efficiently, but acquisition integration can affect margins.
Regulation & reimbursement
Payment policies and regulation materially affect profitability, so investors should monitor policy changes and payer relationships.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
